# A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

> **NCT00660309** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 45 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Irbesartan
- **DRUG:** Captopril

## Key facts

- **NCT ID:** NCT00660309
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660309, "A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00660309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*